Bioventus Names General Counsel Jeanne Forneris to Lead Strategy for the Company, Adds Thomas Umbel to Lead Business Development
DURHAM, NC – May 11, 2015 – Bioventus®, a leader in orthobiologic solutions, today announced changes to its executive leadership team. Jeanne Forneris has been named Vice President of Strategy and General Counsel. Forneris has been a member of the Bioventus executive team since the company’s inception in 2012 serving as Vice President of Business Development and General Counsel. She will continue to report to CEO Tony Bihl and be responsible for leading the strategic planning process, focused on developing a detailed path to the successful achievement of the company’s mission to be a global leader in orthobiologics. Forneris will also be responsible for all of the ethics and compliance functions at Bioventus.
In addition, Bioventus is pleased to announce Thomas Umbel has joined the company as its Vice President of Business Development. Umbel brings more than 30 years of senior executive management experience in medical device and diagnostic companies that range from small start-ups to major corporations. He will be charged with identifying new products and solutions to expand the Bioventus Active Healing Therapies and Bioventus Surgical product offerings. Umbel will join the executive leadership team and report to Tony Bihl.
“We are excited to add Tom to lead business development for Bioventus. His industry experience and contacts will enhance an already strong business development team,” said Tony Bihl. “Jeanne’s presence on the executive team has been invaluable for Bioventus and her new role will allow the company to enjoy greater benefit of her strategic insights. As Bioventus approaches its third anniversary we continue to strengthen and grow in all aspects of our business including senior leadership.”
Forneris has more than 30 years of legal and strategic experience at leading medtech companies and top-tier law firms. Prior to joining Bioventus, she served as Senior Vice President and General Counsel for American Medical Systems Holdings where she led the legal, compliance and health care affairs teams. Prior to joining American Medical Systems Holdings, Forneris was Vice President of Strategic Investments for Medtronic Inc., leading the technology and IP investment and acquisition strategies in support of its Cardiac Rhythm Management business unit. For eight years she served as Vice President and Senior Counsel for Medtronic. She has also served as Vice President and General Counsel for a large construction company and was a private practice attorney. Forneris received her Juris Doctor from the University of Minnesota, and a Bachelor of Arts cum laude in political science and history from Macalester College.
Umbel most recently served as President and COO of OncoGenesis. Prior to that, he spent more than 15 years with Hologic, Inc., first as President of that company’s Direct Radiography business, later as its Vice President of Sales, and finally as its Group Senior Vice President of Development and Marketing. At Hologic, Tom led more than 20 acquisitions of products and businesses to build the strong portfolio of healthcare solutions that Hologic offers today. Earlier in his career, Umbel held various leadership positions within Sterling Diagnostic Imaging and DuPont de Nemours, Inc. He earned a Bachelor of Science degree in chemical engineering from Grove City College.
About Bioventus
Bioventus LLC is an orthobiologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. Bioventus has two product portfolios for orthobiologics, Bioventus Active Healing Therapies and Bioventus Surgical, to make it a global leader in active orthopaedic healing. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide.
For more information, visit www.BioventusGlobal.com and follow the company on Twitter @Bioventusglobal.
Media Contact: Thomas Hill [email protected]
